The 2013 poster (there is no ASCO poster from 2012 or 2014) included only preclinical data on an ongoing phase 1 trial as per ASCO rules. All PK/PD and safety data contained in the poster is from animal studies, and all efficacy data is from human xenografts studies on mice. The current (though limited due to ASCO rules) data all comes from the current trial. You are confusing preclinical data sets with human data sets. Not difficult to do as the two are remarkably similar, and they chart remarkably parallel. All the data in the poster should be considered new because some really does expand on previously that previously PRed and all is validates and confirmes by the lead investigator, himself, previously released info from CTIX.